BRENZAVVY- bexagliflozin: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 April 2024

  • curprev 04:0304:03, 21 April 2024‎ Kosar Doraghi talk contribs‎ 12,281 bytes +198‎ No edit summary
  • curprev 03:4703:47, 21 April 2024‎ Kosar Doraghi talk contribs‎ 12,083 bytes +12,083‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=BRENZAVVY- bexagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=treatment |indication=glycemic control in adults with type 2 diabetes mellitus |hasBlackBoxWarning=Yes |adverseReactions=female genital mycotic infections, urinary tract infection and increased urination |blackBoxWarningTitle=Warnings |blackBoxWarningBody=*Not re..."
Retrieved from "https://www.wikidoc.org/index.php/BRENZAVVY-_bexagliflozin"